Inventor · disambiguated record
Satish Kumar Nachaegari
Also filed as: NACHAEGARI SATISH · NACHAEGARI SATISH K · NACHAEGARI SATISH KUMAR
26 granted patents·36 pending applications·134 citations·filing 2010–2024
96Inventor score
Top patents by PatentIndex Score
62 records- 0198US9498485B2Bioavailable solid state (17-β)-hydroxy-4-androsten-3-one estersLIPOCINE INC·Filed 2015·Granted Nov 22, 2016·23 cites·1 claims
- 0296US11672807B1Oral testosterone non-undecanoate therapyLIPOCINE INC·Filed 2020·Granted Jun 13, 2023·7 cites·53 claims
- 0396US10881670B2Oral testosterone tridecanoate therapyLIPOCINE INC·Filed 2019·Granted Jan 5, 2021·7 cites·42 claims
- 0496US9757389B2Bioavailable solid state (17-β)-hydroxy-4-androsten-3-one estersLIPOCINE INC·Filed 2016·Granted Sep 12, 2017·8 cites·18 claims
- 0595US11992496B1Oral testosterone therapyLIPOCINE INC·Filed 2023·Granted May 28, 2024·2 cites·30 claims
- 0695US10709716B217-hydroxyprogesterone ester-containing oral compositions and related methodsLIPOCINE INC·Filed 2019·Granted Jul 14, 2020·4 cites·12 claims
- 0795US10022384B217-hydroxyprogesterone ester-containing oral compositions and related methodsLIPOCINE INC·Filed 2016·Granted Jul 17, 2018·10 cites·13 claims
- 0895US8951996B217-hydroxyprogesterone ester-containing oral compositions and related methodsGILIYAR CHANDRASHEKAR·Filed 2011·Granted Feb 10, 2015·24 cites·14 claims
- 0994US12161651B1Oral testosterone therapyLIPOCINE INC·Filed 2024·Granted Dec 10, 2024·1 cites·30 claims
- 1094US9399069B217-Hydroxyprogesterone ester containing oral compositions and related methodsLIPOCINE INC·Filed 2015·Granted Jul 26, 2016·9 cites·26 claims
- 1193US11872235B1Bioavailable solid state (17-β)-Hydroxy-4-Androsten-3-one estersLIPOCINE INC·Filed 2022·Granted Jan 16, 2024·1 cites·20 claims
- 1292US11298365B2Bioavailable solid state (17-β)-hydroxy-4-androsten-3-one estersLIPOCINE INC·Filed 2020·Granted Apr 12, 2022·2 cites·23 claims
- 1392US9358299B217-hydroxyprogesterone ester-containing oral compositions and related methodsLIPOCINE INC·Filed 2015·Granted Jun 7, 2016·7 cites·28 claims
- 1490US9364547B217-hydroxyprogesterone ester containing oral compositions and related methodsLIPOCINE INC·Filed 2014·Granted Jun 14, 2016·7 cites·20 claims
- 1590US9358298B217-hydroxyprogesterone ester containing oral compositions and related methodsLIPOCINE INC·Filed 2014·Granted Jun 7, 2016·7 cites·33 claims
- 1689US12303517B1Oral testosterone therapyLIPOCINE INC·Filed 2024·Granted May 20, 2025·0 cites·30 claims
- 1789US12171770B1Bioavailable solid state (17-beta)-hydroxy-4-androsten-3-one estersLIPOCINE INC·Filed 2023·Granted Dec 24, 2024·0 cites·20 claims
- 1888US12097207B1Liver diseaseLIPOCINE INC·Filed 2021·Granted Sep 24, 2024·1 cites·29 claims
- 1987US9375437B2Progesterone containing oral dosage forms and kitsLIPOCINE INC·Filed 2012·Granted Jun 28, 2016·9 cites·62 claims
- 2084US9107921B2Oral dosage forms for oxygen containing active agents and oxyl-containing polymersGILIYAR CHANDRASHEKAR·Filed 2014·Granted Aug 18, 2015·2 cites·22 claims
- 2184US9066942B2Oral dosage forms for oxygen-containing active agents and oxyl-containing polymerSPRIASO LLC·Filed 2014·Granted Jun 30, 2015·2 cites·9 claims
- 2283US12150945B2Liver diseaseLIPOCINE INC·Filed 2019·Granted Nov 26, 2024·1 cites·30 claims
- 2376US11471470B217-hydroxyprogesterone ester-containing oral compositions and related methodsLIPOCINE INC·Filed 2020·Granted Oct 18, 2022·0 cites·19 claims
- 2475US2020046731A1Bioavailable solid state (17- β)-hydroxy-4-androsten-3-one estersLIPOCINE INC·Filed 2019·Application pending·0 cites
- 2572US2019209551A1Oral dosage forms for oxygen-containing active agents and oxyl-containing polymerSPRIASO LLC·Filed 2018·Application pending·0 cites
- 2672US2020022991A1Liver diseaseLIPOCINE INC·Filed 2019·Application pending·0 cites
- 2772US2014303132A1Lipobalanced long chain testosterone esters for oral deliveryLIPOCINE INC·Filed 2014·Application pending·0 cites
- 2872US2014323452A1Lipobalanced long chain testosterone esters for oral deliveryLIPOCINE INC·Filed 2014·Application pending·0 cites
- 2972US2014323453A1Lipobalanced long chain testosterone esters for oral deliveryLIPOCINE INC·Filed 2014·Application pending·0 cites
- 3071US2019175615A1Lipobalanced long chain testosterone esters for oral deliveryLIPOCINE INC·Filed 2018·Application pending·0 cites
- 3170US2018125858A1Bioavailable solid state (17- β)-hydroxy-4-androsten-3-one estersLIPOCINE INC·Filed 2017·Application pending·0 cites
- 3269US2018289724A117-hydroxyprogesterone ester-containing oral compositions and related methodsLIPOCINE INC·Filed 2018·Application pending·0 cites
- 3368US11590147B217-hydroxyprogesterone ester-containing oral compositions and related methodsLIPOCINE INC·Filed 2020·Granted Feb 28, 2023·0 cites·20 claims
- 3468US2014288039A1Lipobalanced long chain testosterone prodrugs for oral deliveryLIPOCINE INC·Filed 2014·Application pending·0 cites
- 3568US2020383998A1Liver DiseaseLIPOCINE INC·Filed 2020·Application pending·0 cites
- 3668US2020390785A1Liver DiseaseLIPOCINE INC·Filed 2020·Application pending·0 cites
- 3768US2013225544A1Lipobalanced long chain testosterone esters for oral deliveryLIPOCINE INC·Filed 2013·Application pending·0 cites
- 3867US11707467B2(17-ß)-3-oxoandrost-4-en-17YL tridecanoate compositions and methods of their preparation and useLIPOCINE INC·Filed 2019·Granted Jul 25, 2023·0 cites·16 claims
- 3967US2018071277A1Oral dosage forms for oxygen-containing active agents and oxyl-containing polymerSPRIASO LLC·Filed 2017·Application pending·0 cites
- 4065US2013172381A1Oral dosage forms for oxygen-containing active agents and oxyl-containing polymerGILIYAR CHANDRASHEKAR·Filed 2012·Application pending·0 cites
- 4165US2019388434A1(17-ß)-3-Oxoandrost-4-En-17-Yl Undecanoate Compositions and Methods of Their Preparation and UseLIPOCINE INC·Filed 2019·Application pending·0 cites
- 4264US2024173334A1Oral (17-ß)-3-Oxoandrost-4-EN-17-YL Tridecanoate TherapyLIPOCINE INC·Filed 2024·Application pending·0 cites
- 4364US2017007623A117-hydroxyprogesterone ester-containing oral compositions and related methodsLIPOCINE INC·Filed 2016·Application pending·0 cites
- 4463US11559530B2Oral testosterone undecanoate therapyLIPOCINE INC·Filed 2017·Granted Jan 24, 2023·0 cites·17 claims
- 4563US2016256454A1Oral dosage forms for oxygen-containing active agents and oxyl-containing polymerSPRIASO LLC·Filed 2016·Application pending·0 cites
- 4663US2018153905A1Oral testosterone tridecanoate therapyLIPOCINE INC·Filed 2017·Application pending·0 cites
- 4763US2015320686A1Oral dosage forms for oxygen-containing active agents and oxyl-containing polymerGILIYAR CHANDRASHEKAR·Filed 2015·Application pending·0 cites
- 4862US2020155575A1Pharmaceutical composition and methodsLIPOCINE INC·Filed 2019·Application pending·0 cites
- 4961US2019240236A1Oral testosterone undecanoate therapyLIPOCINE INC·Filed 2018·Application pending·0 cites
- 5059US2019269700A1Pharmaceutical composition and methodsLIPOCINE INC·Filed 2018·Application pending·0 cites
Showing the top 50 of 62 patent records by PatentIndex Score.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →